Estrogen and progesterone inhibit vascular smooth muscle proliferation

Endocrinology

Volumn 138, Issue 8, 1997, Pages 3330-3339

  Morey, Anjali K ^a,c   Pedram, Ali ^a,b   Razandi, Mahnaz ^a,b   Prins, Bruce A ^a,c   Hu, Ren Ming ^a,b   Biesiada, Elzbieta ^a,b   Levin, Ellis R ^a,b,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE;

ARTICLE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE REPRESSION; HUMAN; HUMAN CELL; MITOGENESIS; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0030737956     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.8.5354     Document Type: Article

References (64)

1. Castelli W 1984 Epidemiology of coronary heart disease: The Framingham Study. Am J Med 76:4-12
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH 1987 Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105-1110
3. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH 1985 A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044-1049
4. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses Health Study. N Engl J Med 325:756-762
5. Stampfer MJ, Colditz GA 1991 Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63
6. Henriksson P, Angelin B, Berglund L 1992 Hormonal regulation of serum Lp(a) levels. J Clin Invest 89:1166-1171
7. Bush TL, Barrett-Conner E 1985 Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 7:89-104
8. Haarbo J, Leth-Espensen P, Stender S, Christiansen C 1991 Estrogen monotherapy and combined estrogen-progesterone replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 87:1274-1279
9. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
10. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415
11. Yanagisawa M, Masaki T 1989 Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10:374-378
12. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F 1991 Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209-215
13. Dubin D, Pratt RE, Cooke JP, Dzau VJ 1989 Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1:150-154
14. Karas RH, Patterson BL, Mendelsohn ME 1994 Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89:1943-1950
15. Frank HJL, Levin ER, Hu R-M, Pedram A 1993 Insulin stimulates endothelin binding and action on cultured vascular smooth muscle. Endocrinology 133:1092-1097
16. Curran T, Gordon NB, Rubino KL, Sambucetti LC 1987 Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modifications in vitro. Oncogene 2:79
17. α gene expression in cultured bovine aortic endothelial cells. Mol Cell Endocrinol 103:65-71
18. Levin ER, Frank HJL 1991 Natriuretic peptides inhibit astroglial proliferation: mediation by C receptor. Am J Physiol 261:R453-R457
19. Prins B, Weber MJ, Hu R-M, Pedram A, Daniels M, Levin ER 1996 Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor: potential role in the inhibition of astrocyte proliferation. J Biol Chem 271:14156-14162
20. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW 1993 Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069
21. Her JH, Lakhani S, Zu K, Vila J, Dent P, Sturgill TW, Weber MJ 1993 Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J 296:25-31
22. Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Geppert, TD, Cobb MH 1993 Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J Biol Chem 268:5097-5106
23. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494
24. Pappas TC, Gametchu B, Yannariello-Brown J, Collins TJ, Watson CS 1994 Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 2:813-822
25. Pappas TC, Gametchu B, Watson CS 1995 Membranes estrogen receptors identified by multiple antibody labelling and impeded ligand binding. FASEB J 9:404-410
26. Berthois Y, Katznellenbogen JA, Katznellenbogen BS 1986 Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500
27. Crews CM, Alessandrini A, Erickson RL 1992 The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258:478-480
28. Kyriakis JM, App H, Zhang H, Banerjee P, Brautigan DL, Rapp UR, Avruch J 1992 Raf-1 activates MAP kinase-kinase. Nature 358:417-421
29. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556
30. White MM, Zamudio S, Stevens T, Tyler R, Lindenfeld J, Leslie K, Moore LG 1995 Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 16:739-751
31. Meizel S, Turner KO 1991 Progesterone acts at the plasma membrane of human sperm. Mol Cell Endocrinol 11:R1-R5
32. Holl JT, Gopal TV, Moulton AD, Nienhuis AW 1986 Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci USA 83:4794-4798
33. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y 1988 Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238:249-252
34. Biro A, Fu Y-M, Yu Z-X, Epstein SE 1993 Inhibitory effects of antisense oliogdeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 90:654-658
35. Bennet MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI 1994 Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oliogdeoxynucleotides. J Clin Invest 93:820-828
36. Magness RR, Rosenfeld CR 1989 Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol 256:E536-E542
37. Reidel M, Rafflenbeul W, Lichtlen P 1993 Ovarian sex steroids and atherosclerosis. Clin Invest 71:406-412
38. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L 1994 The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237-239
39. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM 1994 Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89:1501-1510
40. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P 1993 Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342:133-136
41. Tikkanen MJ 1990 Role of lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects. Am J Obstet Gynecol 163:296-304
42. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR 1991 Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88:1995-2002
43. Haarbo J, Svendsen OL, Christiansen C 1992 Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res 70:1198-1202
44. Miller VM, VanHoutte P 1991 Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 261: R1022-R1027
45. Weiss RH, Maduri M 1993 The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 268:5724-5727
46. Inaba T, Gotoda T, Harada K, Shimada M, Ohsuga J-I, Ishibashi S, Yazaki Y, Yamada N 1995 Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-γ and macrophage colony-stimulating factor in human aortic medial smooth muscle cells. J Clin Invest 95:1133-1139
47. cdc2 and mitogen-activated protein kinase homologues. Circ Res 73:109-117
48. Koide M, Kawahara Y, Tsuda T, Ishida Y, Shii K, Yokoyama M 1992 Endothelin stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J Hypertens 10:1173-1182
49. 44 mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90:8319-8323
50. Adam LP, Franklin MT, Raff GJ, Hathaway DR 1995 Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res 76:183-190
51. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM 1996 Stress-activated protein kinases in cardiovascular disease. Circ Res 78:947-953
52. Janknecht R, Ernst WH, Lingoud V, Nordheim A 1993 Activation of TCF elk-1 by MAP kinases. EMBO J 12:5097-5104
53. Hill CS, Treisman R 1995 Transcriptional regulation by extracellular signals. Cell 80:199-211
54. Hyder SM, Stancel GM, Nawaz Z, McDonnell DP, Loose-Mitchell DS 1992 Identification of an estrogen response element in the 3′-flanking region of the murine c-fos protooncogene. J Biol Chem 267:18047-18054
55. 3-stimulated egr induction. J Biol Chem 270:3642-3647
56. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye J-C 1995 Estrogen synthesis, estrogen metabolism and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 136:1523-1529
57. Lieberherr M, Grosse B, Kachkache M, Balsan S 1993 Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 8:1365-1376
58. Tesaril J, Mendoza C 1995 Nongenomic effects of 17-β-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 80:1438-1443
59. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
60. Rhee CY, Spaet TH, Stemerman MB, Lajam F, Shiang HH, Caruso E, Litwak RS 1977 Estrogen suppression of surgically induced vascular intimal hyperplasia. J Lab Clin Med 90:77-84
61. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML 1991 Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allograft. Transplantation 52:967-972
62. Sullivan Jr TR, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell Jr TF, Mendelsohn ME 1995 Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 96:2482-2488
63. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW 1993 Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 109:612-617
64. Fischer-Dzoga K, Wissler RW, Vesselinovitch D 1983 The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol 39:355-363